|Journal||Inflammatory Bowel Diseases|
|State||Published - Jun 18 2020|
Bibliographical noteFunding Information:
From the Division of Gastroenterology, Department of Internal Medicine, University of Kentucky, USA Supported by: CP is supported by the National Institutes of Health, Grant TL1TR001997 of CCTS funding. The authors’ work is also supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Number R21DK118954. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work was supported in part by Merit Review Award #I01CX001353 to TAB from the United States Department of Veterans Affairs Laboratory Research and Development Program.
- Crohn's disease
- double biologic therapy (DBT)
ASJC Scopus subject areas
- Immunology and Allergy